Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.

Abstract:

BACKGROUND:The objectives of this study were to build a normal tissue complication probability (NTCP) model of radiation-induced hypothyroidism (RHT) for nasopharyngeal carcinoma (NPC) patients and to compare it with other four published NTCP models to evaluate its efficacy. METHODS:Medical notes of 174 NPC patients after radiotherapy were reviewed. Biochemical hypothyroidism was defined as an elevated level of serum thyroid-stimulating hormone (TSH) value with a normal or decreased level of serum free thyroxine (fT4) after radiotherapy. Logistic regression with leave-one-out cross-validation was performed to establish the NTCP model. Model performance was evaluated and compared by the area under the receiver operating characteristic curve (AUC) in our NPC cohort. RESULTS:With a median follow-up of 24 months, 39 (22.4%) patients developed biochemical hypothyroidism. Gender, chemotherapy, the percentage thyroid volume receiving more than 50 Gy (V50), and the maximum dose of the pituitary (Pmax) were identified as the most predictive factors for RHT. A NTCP model based on these four parameters were developed. The model comparison was made in our NPC cohort and our NTCP model performed better in RHT prediction than the other four models. CONCLUSIONS:This study developed a four-variable NTCP model for biochemical hypothyroidism in NPC patients post-radiotherapy. Our NTCP model for RHT presents a high prediction capability. TRIAL REGISTRATION:This is a retrospective study without registration.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Luo R,Wu VWC,He B,Gao X,Xu Z,Wang D,Yang Z,Li M,Lin Z

doi

10.1186/s12885-018-4348-z

subject

Has Abstract

pub_date

2018-05-18 00:00:00

pages

575

issue

1

issn

1471-2407

pii

10.1186/s12885-018-4348-z

journal_volume

18

pub_type

杂志文章
  • The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospital-based matched case-control study.

    abstract:BACKGROUND:Previous studies have found that polymorphisms of the DNA repair gene X-ray repair cross-complementing group 1(XRCC1) and environmental factors are both associated with an increased risk of stomach cancer, but no study has reported on the potential additive effect of these factors among Thai people. The aim ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3675-9

    authors: Putthanachote N,Promthet S,Hurst C,Suwanrungruang K,Chopjitt P,Wiangnon S,Chen SL,Yen AM,Chen TH

    更新日期:2017-10-11 00:00:00

  • The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.

    abstract:BACKGROUND:High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5439-1

    authors: Klenke S,Akdeli N,Stelmach P,Heukamp L,Schulte JH,Bachmann HS

    更新日期:2019-03-18 00:00:00

  • Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma.

    abstract:BACKGROUND:DNA methylation changes occurring in cancer cells are featured with both promoter CpG island hypermethylation and diffuse genomic hypomethylation. Long interspersed element-1 (LINE-1) is repeated in an interspersed manner with an estimated 500,000 copies per genome. LINE-1 has its CpG sites of the 5' untrans...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3595-8

    authors: Jeong S,Lee K,Wen X,Kim Y,Cho NY,Jang JJ,Kang GH

    更新日期:2017-08-29 00:00:00

  • Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.

    abstract:BACKGROUND:For the expanding population of bladder cancer survivors in Korea, the development of subsequent cancers is a significant concern. Here, we provide the second primary cancer incidence rates and types in Korean patients with bladder cancer. METHODS:Using population-based data from the Korea Central Cancer Re...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4530-3

    authors: Kwon WA,Joung JY,Lim J,Oh CM,Jung KW,Kim SH,Seo HK,Park WS,Chung J,Lee KH,Won YJ

    更新日期:2018-05-31 00:00:00

  • Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.

    abstract:BACKGROUND:Hyponatraemia is a common finding in patients with cancer, and has been shown to be associated with poor prognosis in different settings. We have analysed the impact of severe hyponatraemia in patients with cancer. METHODS:A retrospective review of all patients admitted to a specialist cancer hospital with ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1156-6

    authors: Balachandran K,Okines A,Gunapala R,Morganstein D,Popat S

    更新日期:2015-03-22 00:00:00

  • Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.

    abstract:BACKGROUND:Standard radiotherapy is the treatment of first choice in patients with symptomatic spinal metastases, but is only moderately effective. Stereotactic body radiation therapy is increasingly used to treat spinal metastases, without randomized evidence of superiority over standard radiotherapy. The VERTICAL stu...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-016-2947-0

    authors: van der Velden JM,Verkooijen HM,Seravalli E,Hes J,Gerlich AS,Kasperts N,Eppinga WS,Verlaan JJ,van Vulpen M

    更新日期:2016-11-21 00:00:00

  • Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis.

    abstract:BACKGROUND:It is not known what combination of bevacizumab and chemotherapy agents is the best therapeutic regimen. Comparative study results among the efficacies of bevacizumab plus chemotherapy remain controversial in patients with HER2-negative metastatic breast cancer. METHODS:We searched Pubmed, Embase, and Cochr...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-020-6674-1

    authors: Sun Z,Lan X,Xu S,Li S,Xi Y

    更新日期:2020-03-04 00:00:00

  • Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.

    abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a type of neoplasm that is highly prevalent in East Asia and Africa with Epstein-Barr virus (EBV), genetic, and dietary factors implicated as possible aetiologic factors. Previous studies suggested the association of certain cytokines with the invasion and metastatic propert...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-574

    authors: Chew MM,Gan SY,Khoo AS,Tan EL

    更新日期:2010-10-22 00:00:00

  • A multilevel investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer.

    abstract:BACKGROUND:In Australia, breast cancer is the most common cancer affecting Australian women. Inequalities in clinical and psychosocial outcomes have existed for some time, affecting particularly women from rural areas and from areas of disadvantage. We have a limited understanding of how individual and area-level facto...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-415

    authors: Youl PH,Baade PD,Aitken JF,Chambers SK,Turrell G,Pyke C,Dunn J

    更新日期:2011-09-28 00:00:00

  • Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.

    abstract:BACKGROUND:Whether chronic inflammation increases prostate cancer risk remains unclear. This study investigated whether chronic inflammatory diseases (CID) or anti-inflammatory medication use (AIM) were associated with prostate cancer risk. METHODS:Fifty-five thousand nine hundred thirty-seven cases (all prostate canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5846-3

    authors: Beckmann K,Russell B,Josephs D,Garmo H,Haggstrom C,Holmberg L,Stattin P,Van Hemelrijck M,Adolfsson J

    更新日期:2019-06-21 00:00:00

  • Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

    abstract:BACKGROUND:Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between ctDNA levels and the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4637-6

    authors: McEvoy AC,Warburton L,Al-Ogaili Z,Celliers L,Calapre L,Pereira MR,Khattak MA,Meniawy TM,Millward M,Ziman M,Gray ES

    更新日期:2018-07-09 00:00:00

  • Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study.

    abstract:BACKGROUND:To assess the relationship between responses within 1 year and health-related quality of life (HRQoL) outcomes by exploring profiles of patients with CML-CP who were treated with front-line imatinib or nilotinib. METHODS:A prospective, longitudinal, single-center study was conducted to assess the response t...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-018-4699-5

    authors: Yu L,Wang H,Milijkovic D,Huang X,Jiang Q

    更新日期:2018-08-03 00:00:00

  • HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.

    abstract:BACKGROUND:Accurate assessment of HER-2/neu status is crucial for proper prognostic information and to offer direct appropriate treatment for breast cancer patients. Next to immunohistochemistry (IHC) to evaluate HER2 protein overexpression, a second line gene amplification test is generally deemed necessary for cases ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-4

    authors: Moelans CB,de Weger RA,Ezendam C,van Diest PJ

    更新日期:2009-01-05 00:00:00

  • Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.

    abstract:BACKGROUND:Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell carcinoma of the head and neck (SCCHN). Dose-dense chemotherapy may yield favorable outcomes compared with standard-dose chemotherapy, yet the ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07347-6

    authors: Hsieh CY,Lein MY,Yang SN,Wang YC,Lin YJ,Lin CY,Hua CH,Tsai MH,Lin CC

    更新日期:2020-09-01 00:00:00

  • Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.

    abstract:BACKGROUND:Molecular alterations occur frequently in T-ALL and the potential impact of those abnormalities on outcome is still controversial. The current study aimed to test whether NOTCH1 mutations and additional molecular abnormalities would impact T-ALL outcome in a series of 138 T-ALL paediatric cases. METHODS:T-A...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-9

    authors: Mansur MB,Hassan R,Barbosa TC,Splendore A,Jotta PY,Yunes JA,Wiemels JL,Pombo-de-Oliveira MS

    更新日期:2012-01-06 00:00:00

  • CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.

    abstract:BACKGROUND:In past decades, circular RNAs (circRNAs) have achieved increasing attention because of its regulatory role in different kinds of cancers. However, how circAGFG1 regulates cervical cancer (CC) is still largely undiscovered. This study aims to evaluate the role of a novel circRNAs and related molecular mechan...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6269-x

    authors: Wu F,Zhou J

    更新日期:2019-11-08 00:00:00

  • LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.

    abstract:BACKGROUND:Long non-coding RNAs have been shown to have critical regulatory roles in cancer biology. However, the contributions of lncRNAs to gastric cancer remain largely unknown. METHODS:The differential expression of lncRNAs in gastric cancer and paired non-cancerous tissues were identified by microarray and valida...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-932

    authors: Han Y,Ye J,Wu D,Wu P,Chen Z,Chen J,Gao S,Huang J

    更新日期:2014-12-11 00:00:00

  • Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.

    abstract:BACKGROUND:Higher sunlight exposure is correlated with lower incidence of breast cancer in ecological studies, but findings from prospective studies regarding the association of circulating levels of vitamin D with the risk of breast cancer have been null. The objective of this study was to examine the relation between...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-29

    authors: Kim Y,Franke AA,Shvetsov YB,Wilkens LR,Cooney RV,Lurie G,Maskarinec G,Hernandez BY,Le Marchand L,Henderson BE,Kolonel LN,Goodman MT

    更新日期:2014-01-17 00:00:00

  • FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes.

    abstract:BACKGROUND:FAM3B/PANDER is a novel cytokine-like protein that induces apoptosis in insulin-secreting beta-cells. Since in silico data revealed that FAM3B can be expressed in prostate tumors, we evaluated the putative role of this cytokine in prostate tumor progression. METHODS:FAM3B expression was analyzed by quantita...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3950-9

    authors: Maciel-Silva P,Caldeira I,de Assis Santos I,Carreira ACO,Siqueira FR,Antonioli E,Goldberg AC,Belizário JE,Garay-Malpartida HM

    更新日期:2018-01-22 00:00:00

  • M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas.

    abstract:BACKGROUND:Recent progress in molecular analysis has advanced the understanding of medulloblastoma (MB) and is anticipated to facilitate management of the disease. MB is composed of 4 molecular subgroups: WNT, SHH, Group 3, and Group 4. Macrophages play a crucial role in the tumor microenvironment; however, the functio...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4457-8

    authors: Lee C,Lee J,Choi SA,Kim SK,Wang KC,Park SH,Kim SH,Lee JY,Phi JH

    更新日期:2018-05-08 00:00:00

  • Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P.

    abstract:BACKGROUND:Endometrial cancer, one of the most common malignant tumors, is a serious threat to women's health. Endometrial hyperplasia is a precursor of endometrial cancer. S100 calcium binding protein P (S100P) has been found to play important roles in many types of cancer. The present study aimed to investigate the e...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07350-x

    authors: Zhang D,Chen X,Xia H,Wang L,Zhao H,Xu B,Zhang A,Zhang W

    更新日期:2020-09-03 00:00:00

  • Protein kinase Cepsilon is important for migration of neuroblastoma cells.

    abstract:BACKGROUND:Migration is important for the metastatic capacity and thus for the malignancy of cancer cells. There is limited knowledge on regulatory factors that promote the migration of neuroblastoma cells. This study investigates the hypothesis that protein kinase C (PKC) isoforms regulate neuroblastoma cell motility....

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-365

    authors: Stensman H,Larsson C

    更新日期:2008-12-11 00:00:00

  • Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.

    abstract:BACKGROUND:The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment. METHODS:Between January 1996 and December 2006, a total of 1367 CRC patients who ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-288

    authors: Sun LC,Chu KS,Cheng SC,Lu CY,Kuo CH,Hsieh JS,Shih YL,Chang SJ,Wang JY

    更新日期:2009-08-20 00:00:00

  • The effect of metformin and thiazolidinedione use on lung cancer in diabetics.

    abstract:BACKGROUND:Metformin and the thiazolidinediones (TZDs) may have a protective effect against the development of lung cancer. METHODS:Patients with diabetes mellitus (DM) were identified from the electronic medical records of the Cleveland Clinic. Diabetics with lung cancer were identified then verified by direct review...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-410

    authors: Mazzone PJ,Rai H,Beukemann M,Xu M,Jain A,Sasidhar M

    更新日期:2012-09-14 00:00:00

  • Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

    abstract:BACKGROUND:The Nijmegen Breakage Syndrome is a chromosomal instability disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased frequency of cancers. Familial studies on relatives of these patients indicated that they also appear to be at increased risk of cancer. METHODS:In a candid...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-181

    authors: Desjardins S,Beauparlant JC,Labrie Y,Ouellette G,Durocher F,INHERIT BRCAs.

    更新日期:2009-06-12 00:00:00

  • Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.

    abstract:OBJECTIVE:Crizotinib can target against mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK), which has been considered as a multi-targeted tyrosine kinase inhibitor (TKI). The objective of this study was to explore the efficacy of crizotinib in advanced non-small-cell lung cancer (NSCLC) with c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5078-y

    authors: Chen RL,Zhao J,Zhang XC,Lou NN,Chen HJ,Yang X,Su J,Xie Z,Zhou Q,Tu HY,Zhong WZ,Yan HH,Guo WB,Wu YL,Yang JJ

    更新日期:2018-11-26 00:00:00

  • Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment.

    abstract:BACKGROUND:The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of cell growth and survival signaling as well transformation induced by multiple tyrosine kinase oncogenes. Since the basal-like and triple-negative breast cancer (BTBC) is characterized by dysregulation of multiple tyrosine kinase o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1131-2

    authors: Zhao H,Agazie YM

    更新日期:2015-03-08 00:00:00

  • Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study.

    abstract:BACKGROUND:There is limited real-world safety information on palbociclib for treatment of advanced stage HR+/HER2- breast cancer. METHODS:We conducted a cohort study of breast cancer patients initiating palbociclib and fulvestrant from February 2015 to September 2017 using the HealthCore Integrated Research Database (...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-021-07790-z

    authors: Beachler DC,de Luise C,Jamal-Allial A,Yin R,Taylor DH,Suzuki A,Lewis JH,Freston JW,Lanes S

    更新日期:2021-01-25 00:00:00

  • Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.

    abstract:BACKGROUND:The numerous side effects of chemotherapy in patients with breast cancer are well known. However, the precise effects of chemotherapy on ovarian function in premenopausal women are poorly investigated. The patients are at risk of developing sexual hormone deficiency and impaired fertility. This prospective c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3593-x

    authors: Wenners A,Grambach J,Koss J,Maass N,Jonat W,Schmutzler A,Mundhenke C

    更新日期:2017-09-06 00:00:00

  • Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.

    abstract:BACKGROUND:Solitary plasmacytoma (SP) is a localized neoplastic plasma cell disorder with an annual incidence of less than 450 cases. Given the rarity of this disorder, it is difficult to conduct large-scale population studies. Consequently, very limited information on the disorder is available, making it difficult to ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-3015-5

    authors: Thumallapally N,Meshref A,Mousa M,Terjanian T

    更新日期:2017-01-05 00:00:00